Transcription Factors

2,997 views
2,775 views

Published on

hemato biology

Published in: Technology
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
2,997
On SlideShare
0
From Embeds
0
Number of Embeds
21
Actions
Shares
0
Downloads
103
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Transcription Factors

  1. 2. transcription factors By Najmaldin Saki Sprin 2008
  2. 4. HOXB < HOXA
  3. 6. Bmi1 Cdkn1a Pten Etv6 Mcl1 HoxB4 HSCs Wnt pathway Ang-1 Notch ligand Gp130 Ligands TNF Alpha Stem cells
  4. 7. HSC expansion for clinical use via gene therapy HSC progeny <ul><li>General hematopoiesis </li></ul>
  5. 8. Bre:brain and reproductive organ-expressed protein
  6. 9. HOXB4 TNFR1 Bre Inhibit (TNF Alpha ,Fas Ligand ,various other stress-related stimuli)
  7. 10. Fig. 3. Induction of HOXB4 activity protects cultivated HSCs from the negative effects TNF-{alpha} on stem cell self-renewal 4-hydroxytamoxifen(TMX)-inducible Form of HoxB4(HoxB4)
  8. 11. Two member of the negative feedback loop of FGF signaling Phosphorylated in response to FGF signaling Chemical blockage of FGF signaling augmented the long-term repopulation activity of HOXB4-expressing HSCs/HPCs in vitro
  9. 12. HOXB4 Modulate Wnt and Notch signaling Hbp1 :transcriptional repressor of Wnt target genes
  10. 13. The core of the pathway is conserved from worms and flies to mammals.(Left) At the heart of the pathway, the destruction complex consisting of GSK-3,APC, and axin captures and phosphorylates -catenin. The latter is then recognized by TrCP and ubiquitinated by an associated E3 ligase complex. Subsequently,-catenin is degraded by the proteasome. Meanwhile, TCF/LEF is bound by corepressors such as Groucho (Grg) and represses target gene transcription.(Right) When Wnt factors ligate to their cell surface receptors, the kinase activity of the destruction complex is inhibited by dishevelled (Dsh).As a consequence,-catenin accumulates and travels to the nucleus where it binds to TCF/LEF transcription factors. The resulting complex potently activates transcription of target genes. HOXB4 HOXB4 : Wnt( Narf,Nlk ) & Notch( Nrarp )
  11. 14. <ul><li>Mutation or substitution of a HOX gene can lead to the replacement of one body part by an other, reflecting the key significance of these genes in determining cellular identity. </li></ul><ul><li>Retrovirally driven HOXB4 expression in transduced adult HSC poulations leads to a 1000-fold net increase in growth,without any apparent reduction in the ability of these cells to subsequently differentiate into lymphoid and myloid lineages,and without the cells becoming transformed. </li></ul>How dose HOXB4 promote HSC proliferation?
  12. 15. Positive regulation by HOX proteins requires the binding of a number of co-factors , most notably members of the PBX and MEIS transcription factor families. Convert chromatin to an inative state The activation of transcription may require additional factors to bind to other genes enhancer,and these factors may only be available in specific cells and tissues C-myc Notch In addition to c-myc two components of the AP-1 Transcriptional activation complex , Jun -B & Fra -1 are also upregulated by HOXB4 HOXB4 is not the first example of a transcription factor that can both activate and repress apoptosis. One of the best characterised is the Rel/NF-ĸB transcription factor, which has both anti-and proapoptopic roles in T-cells. Rel/NF-ĸB HOXB4 Activating proapoptopic genes Activating proapoptopic genes Activation antiapoptopic genes Activation antiapoptopic genes Actively promotes proliferation
  13. 16. SMAD 2/3 P SMAD 2/3 SMAD 4 SMAD 4 P SMAD 2/3 TGF-b SMAD 4 P SMAD 2/3 P AKT IKKb SMAD 4 P SMAD 2/3 SMAD 4 P SMAD 2/3 P21/cip BIM FasL PAI-1 TGIF TIEG Growth arrest Apoptosis TIEG <ul><li>Smad2 </li></ul><ul><li> Smad7 </li></ul>Growth factor cytokines Nucleus STAT-5 BAD P Survival Apoptosis Survival and apoptotic signaling pathways DUSP6 (survival) PIP3 PDK1 PI3K P38 MAPK  CM  EM  EM  CM  EM  CM FOXO FOXO FOXO - PIM2 BAD - PTEN
  14. 17. SMAD 2/3 P SMAD 2/3 SMAD 4 SMAD 4 P SMAD 2/3 TGF-b SMAD 4 P SMAD 2/3 SMAD 4 P SMAD 2/3 PAI-1 TGIF TIEG Growth arrest Apoptosis TIEG <ul><li>Smad2 </li></ul><ul><li> Smad7 </li></ul>Nucleus  EM TGF-beta pathway <ul><li>EM </li></ul><ul><li>Gene Array </li></ul>- -
  15. 18. The transcription factor PU.1 is an essential regulator of haemopoiesis and a suppressor of myeloid leukaemia. Enforced expression of PU.1 in haemopoietic progenitors has suggested an instructive role of PU.1 in promoting macrophage an ddendriticcell (DC) development. PU.1 performs these important roles by regulating numerous genes within the myeloid and lymphoid lineages, including those encoding many ofthe developmentally important cytokine receptors, for example macrophage colony-stimulating factor receptor (M-CSFR) ,granulocyte–macrophage colony-stimulating factor receptor (GM-CSFR) Alpha and interleukin (IL)-7R Alpha , and by interacting with several other key transcription factors, including interferon regulatory factor (IRF)4, IRF8, acute myeloid leukaemia (AML)-1,CCAAT/ enhancer-binding protein (C/EBP)a ,GATA-binding protein-1 (GATA-1) and c-Jun. However, the lethality andlack oflong-term repopulatingstem cell activity associated with germline PU.1-deficiency has, until recently,precluded afullanalysis of PU.1function in adult haemopoiesis.Subsequently, overexpression studies demonstrated that continuous expression of high PU.1 levels, while permissive for macrophage development, could partially block erythroid differentiation and completely block early phases of B cell and Tcell development. recent study has even demonstrated an ability of PU.1 to reprogramme committed T cell progenitors into dendritic-like cells.
  16. 20. Central role of PU.1 in leukaemogenesis. Schematic of the human and mouse leukaemias in which the modulation of PU.1 function is thought to be important. Red arrows indicate the relative PU.1 activity compared with non-malignant haemopoietic progenitors. Abbreviations: DBD, PU.1 DNA-binding domain.
  17. 21. Pax5 and commitment to the B cell lineage <ul><li>E2A and EBF are needed to turn on B cell specific genes including Pax5, which turns on additional B cell-specific genes </li></ul>
  18. 22. Putting it all together: growth factors + transcription factors in B cell development
  19. 23. Figure 2. B-cell development and the roles of EBF. (a) Progressive stages of B-cell lymphopoiesis are shown with (i) cell designations indicated below, (ii) the status of V(D)J recombination indicated within each cell type and (iii) characteristic cell surface markers indicated above each cell. B-biased progenitors represent the CLP-2 stage in other models of development [1]. The approximate points at which B-cell lymphopoiesis is arrested in PU.1K/K, E2AK/K, EBFK/K and Pax5K/K mice are indicated above the cells. Cells lacking EBF or E2A closely resemble B-biased progenitor cells but lack all Ig gene rearrangements. (b) Central role of EBF in B-cell development. Regulatory circuits in developing B cells are shown to highlight the functions of EBF. Transcription of the ebf1 gene is a function of the transcription factors PU.1 [19] and E2A [32] and is reinforced by IL-7R signaling [35,36]. EBF might autoregulate its own expression [18]. EBF regulates genes, including pax5 [17], RAG-1 [15], l5 and VpreB1 [15], B29 [51], B-lymphoid tyrosine kinase (blk) [52] and CD19 [53]. Many EBF targets have been confirmed as targets of E2A, which functions in synergy with EBF [33]. A role for EBF in the regulation of E2A expression in the B-cell compartment (broken line) is suggested by the reduction of E2A in the absence of EBF [15]. Pax5, in turn, regulates mb-1 and CD19 synergistically with EBF [40]. Pax5 regulates many other genes required for the B-lineage program and commitment (reviewed in Ref. [1]). Abbreviations: LinK, lineage-specific markers.
  20. 24. A Schematic Diagram of Regulatory Network Controlling Plasma Cell Differentiation Our results suggest the diminishing of Bcl-6 as a primary event in the development of plasmacytic phenotype in Pax5-deficient DT40 cells, since Pax5 is not essential to the inhibition of Blimp-1. Thus, Pax5 is more likely needed to maintain Bcl-6 level (dashed arrow) at later stages of B cell development. The solid lines indicate the previously known inhibitory signals of this regulatory network .
  21. 26. Functional roles and target genes of E2A, EBF and Pax5. E2A and EBF cooperate in the specification of the B cell fate. These transcription factors regulate the expression of immunoglobulin surrogate light chain genes λ5, VpreB, the recombinase activating genes Rag1, and the mb1, B29 genes, which encode components of the pre-BCR and BCR. Pax5, which is under the control of E2A and EBF, regulates the commitment step of B cell differentiation, in which the expression of signaling receptors that determine alternative lineage choices (Notch, M-CSF-R) are repressed. Pax5 activates the expression of the B cell determinants mb-1, CD19 and BLNK/SLP65/BASH (B cell linker protein) as well as the recombination of distal variable gene segments.
  22. 27. Lineage commitment in the bone marrow. The position of the transcription factors on the scheme represents the stage at which their absence (based usually on knockout studies) leads to a developmental block. Proteins normally acting as inhibitors of the differentiation pathways are depicted in red. Physical interactions between transcription factors are indicated by double-pointed blue arrows. SC, stem cell; HSC, hematopoietic stem cell; CLP, common lymphoid progenitor; NK, natural killer cell.
  23. 28. Transcription factors in plasma cell differentiation. At the GC B cell stage, BCL-6 represses Blimp-1, a key regulator of plasma cell differentiation. Another transcription factor crucial in plasma cells, XBP-1 is repressed by Pax-5. Upon transition to the plasma cell stage, Blimp-1 expression leadstothe repression of BCL-6 transcription, and thereby to the inhibition of earlier GC B cell activities, including the transcription of a number of B cell specific transcription factors, such as Pax-5. As a consequence of Pax-5 downregulation, XBP-1, specifically required for plasma cell development, is expressed.
  24. 29. Structure of the vertebrate family of GATA proteins. All 6 vertebrate GATA factors share a conserved DNA-binding domain consisting of 2 zinc fingers (ZnF), a feature that defines this family of transcription factors. The different GATA factors can be divided into 2 subgroups based on amino acid sequence homology and tissue distribution: the hematopoietic subgroup (GATA 1/2/3) and the cardiac subgroup (GATA 4/5/6). Transac- tivation domains are found in either the N-terminal (N-term) and/or C-terminal (C-term) portions of the different GATA proteins. NLS, nuclear localization signal.
  25. 30. Proposed model for GATA factors as effectors of hormonal signaling in testicular cells. In the testis, Sertoli and Leydig cell gene expression and function are tightly regulated by the pituitary trophic hormones follicle-stimulating hormone (FSH) and leutinizing hormone (LH), respectively. Hormone binding to G-protein coupled cell surface receptors activates adenylate cyclase (AC), leading to increased intracellular cAMP levels. cAMP then binds the regulatory (R) subunit of protein kinase A (PKA), allowing dissociation of the PKA catalytic (C) subunit and its translocation to the nucleus, where it phosphorylates target proteins. In both Sertoli and Leydig cells, GATA factors are novel targets for PKA-mediated phosphorylation. As shown, phosphorylation of GATA4 at serine 261 allows for an enhanced cooperation with multiple transcriptional partners and the recruitment of the CBP coactivator. The end result is increased expression of hormonally regulated GATA-dependent target genes such as steroidogenic acute regulatory protein (Star), inhibin � (Inha), and P450 aromatase (Cyp19 ).
  26. 31. Model for the dynamic regulation of GATA1 during haematopoiesis. The relative expression levels of the mouse GATA1 gene are indicated by various colors as shown in the box. Red arrows indicate the stages of differentiation which are inhibited when the expression levels of GATA1 are genetically altered in mice. Note that the expression levels in the testis, eosinophil and mast cell are imprecise. CLP, common lymphoid progenitor; CMP, common myeloid progenitor; ES, embryonic stem; HSC, haematopoietic stem cell; MEP, megakaryocyte/erythrocyte lineage-restricted progenitor; ProE, proerythroblast.
  27. 32. Model of Th17 lineage development. The differentiation of Th17 cells is initiated by the activation of naı¨ve T cells in the presence of IL-6 plus TGF-b. This leads to the expression of ROR-gt and production of IL-17. IL-6, produced by the innate immune system, is crucial during this phase but when this cytokine is not present and T-reg cells are eliminated, IL-21 produced by NK cells and NK T cells together with TGF-b can initiate an alternate pathway of Th17 differentiation. Upon differentiation, IL-21 is also massively induced by the developing Th17 cells and acts in autocrine fashion on Th17 cells to amplify this population. Then, IL-23 stabilizes previously differentiated Th17 cells and enables further expansion of the Th17 lineage with sustained production of its hallmark cytokines.

×